Galectin-1在头颈部鳞状细胞癌中的研究进展
Galectin-1 and Squamous Cell Carcinoma of the Head and Neck
摘要
头颈部鳞状细胞癌（head and neck squamous cell carcinoma，HNSCC）是常见的头颈部疾病，其发病率居恶性肿瘤第六位。目前，手术联合放疗、化疗是HNSCC的主要治疗手段。肿瘤免疫治疗是在现代肿瘤免疫学理论的基础上。结合免疫生物学、分子生物学等诸学科的发展而形成的一种治疗手段。因为其效果明显且副作用小，成为综合治疗最主要的辅助手段并广泛应用于临床。
出处
《口腔颌面外科杂志》
CAS
2009年第2期134-136,共3页
Journal of Oral and Maxillofacial Surgery
参考文献21
-
1Ferris RL. Progress in head and neck cancer immunotherapy: can tolerance and immune suppression be reversed [J]. ORL J Otorhinolaryngol Relat Spec, 2004, 66(6):332- 340.
-
2程杰,王佐林.肿瘤干细胞研究进展[J].口腔颌面外科杂志,2006,16(3):263-266. 被引量：1
-
3Camby I, Lemercier M, Lefranc F, et al. Galectin-1: a small protein with major functions[J]. Glycobiology, 2006, 16(11): 137R- 157R.
-
4Perillo NL, Pace KE, Seilhamer JJ, et al. Apoptosis of T cells mediated by Galectin-1[J]. Nature, 1995, 378(6558): 736-739.
-
5Liu FT, Rabinovich GA. Galectins as modulators of tumor progression[J]. Nat Rev Cancer, 2005, 5(1):29-41.
-
6Sotomayor CE, Rabinovich GA. Galectin-1 induces central and peripheral cell death: implications in T-cell physiopathology[J]. Dev Immunol, 2000, 7(2-4):117-129.
-
7Garin MI, Chu CC, Golshayan D, et al. Galectin-1: a key effector of regulation mediated by CD4^+CD25^+ T cells[J]. Blood, 2007, 109(5):2058-2065.
-
8He J, Baum LG. Presentation of galectin-1 by extracellular matrix triggers T cell death[J]. J Biol Chem, 2004, 279(6): 4705-4712.
-
9Matarrese P, Tinari A, Mormone E, et al. Galeetin-1 sensitizes resting human T lymphoeytes to Fas (CD95)-mediated eell death via mitoehondrial hyperpolarization, budding, and fission[J]. J Biol Chem, 2005, 280(8):6969-6985.
-
10Rabinovich GA. Galectin-1 potential cancer target[J]. Br J Cancer, 2005, 92(7):1188-1192.
二级参考文献31
-
1Fang D,Nguyen TK,Leishear K,et al.A tumorigenic subpopulation with stem cell properties in melanomas[J].Cancer Res,2005,65 (20):9328-9337.
-
2Collins AT,Berry PA,Hyde C,et al.Prospective identification of tumorigenic prostate cancer stem cells[J].Cancer Res,2005,65 (23):10946-10951
-
3Zhou S,Schuetz JD,Bunting KD,et al.The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the sidepopulation phentotype[J].Nat Med,2001,7 (9):1028-1034.
-
4Kondo T,Setoguchi T,Taga T Persistence of a small subpopulation of cancer stem-like cells in C6 glioma cell line[J].Proc Natl Acad Sci USA,2004,101(3):781-786.
-
5Chen JS,Pardo FS,Wang-Rodriguez J,et al.EGFR regulates the side population in head and neck squamous cell carcinoma[J].Laryngoscope,2006,116(3):401-406.
-
6Cozzio A,Passegué E,Paul MA,et al.Similar MLL-associated leukemias arising from self-reviewing stem cells and short-lived myeloid progenitors[J].Genes Dev,2003,17(24):3029-3035.
-
7Serakinci N,Guldberg P,Burns JS,et al.Adult human mesenchymal stem cell as a target for neoplastic transformation[J].Oncogene,2004,23(29):5095-5099
-
8Reya T,Clevers H.Wnt signaling in stem cells and cancer[J].Nature,2005,434(7035):843-850.
-
9Taipale J,Beachy PA.The hedgehog and Wnt signaling pathways in cancer[J].Nature,2001,411(6835):349-354.
-
10Kerinek V,Nick B,Petra M,et al.Depletion of epithelial stem cell compartment in the small intestine of mice lacking TCF-4[J].Nature Genetics,1998,19(4):379-383.
-
1林晓勇,王一北.胰腺癌的免疫治疗[J].中国卫生产业,2011,8(11Z):83-83.
-
2熊玉芝.氟达拉滨治疗慢性粒细胞白血病的护理[J].中国现代药物应用,2008,2(18):93-94. 被引量：2
-
3Urosevic M.,Kempf W.,Zagrodnik B.,王琼.放疗后复发性皮肤基底细胞癌HLA-G的表达[J].世界核心医学期刊文摘（皮肤病学分册）,2005,0(9):37-37.
-
4刘弦,黄桂林.头颈部恶性肿瘤前哨淋巴结的研究进展[J].遵义医学院学报,2013,36(2):180-183.
-
5侯铁宁,杨占泉,宋建国,王微.血管造影与血管栓塞术在头颈部疾病中的应用[J].临床耳鼻咽喉科杂志,1992,6(2):78-80. 被引量：8
-
6江飞,陈宁.环氧化酶-2与头颈部鳞癌的相关研究进展[J].口腔生物医学,2010,1(1):37-39.
-
7王莹颖,华清泉,张志坚.CD44、CD133在头颈部鳞状细胞癌中的表达及临床意义[J].现代预防医学,2010,37(11):2147-2149. 被引量：2
-
8沈世强,姚峰.肝癌的生物治疗[J].腹部外科,2005,18(2):83-85. 被引量：1
-
9曾而明,袁贤瑞.胶质瘤免疫生物学研究进展[J].国际神经病学神经外科学杂志,2005,32(4):362-365.
-
10施广霞,程一櫂,郭连英,王艳,于丽华,钱振超.抗CD3单抗和rIL-2共刺激诱生扩增人CD3AK的实验研究Ⅱ CD3AK的免疫生物学特征[J].中国肿瘤生物治疗杂志,1995,2(4):267-268. 被引量：2
